flurbiprofen has been researched along with Ankylosing Spondylarthritis in 13 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Flurbiprofen, a phenylalkanoic acid derivative, is a non-steroidal anti-inflammatory, antipyretic, analgesic agent advocated for use in rheumatoid arthritis, degenerative joint disease, ankylosing spondylitis and allied conditions." | 8.76 | Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases. ( Avery, GS; Brogden, RN; Heel, RC; Speight, TM, 1979) |
| "The safety of flurbiprofen (Ansaid, Upjohn) was assessed after pooling data on kidney and liver function collected from nine separate phase III clinical trials involving 1,677 patients (941 receiving flurbiprofen and 736 receiving comparison drugs) with ankylosing spondylitis, osteoarthritis, or rheumatoid arthritis." | 7.67 | Safety of flurbiprofen in the treatment of ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis. A summary of liver and kidney assay data. ( Lamborn, KR; Lomen, PL; Turner, LF, 1986) |
| "Flurbiprofen, a phenylalkanoic acid derivative, is a non-steroidal anti-inflammatory, antipyretic, analgesic agent advocated for use in rheumatoid arthritis, degenerative joint disease, ankylosing spondylitis and allied conditions." | 4.76 | Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases. ( Avery, GS; Brogden, RN; Heel, RC; Speight, TM, 1979) |
| " Two hundred patients presenting with classic rheumatic diseases (osteoarthritis, n = 50; rheumatoid arthritis, n = 130; ankylosing spondylitis, n = 20) were given a daily dose of 200 mg sustained-release flurbiprofen (flurbiprofen SR)." | 3.70 | Six-month prospective study to monitor the treatment of rheumatic diseases with sustained-release flurbiprofen. ( Miceková, D; Rovenský, J, 2000) |
| "The safety of flurbiprofen (Ansaid, Upjohn) was assessed after pooling data on kidney and liver function collected from nine separate phase III clinical trials involving 1,677 patients (941 receiving flurbiprofen and 736 receiving comparison drugs) with ankylosing spondylitis, osteoarthritis, or rheumatoid arthritis." | 3.67 | Safety of flurbiprofen in the treatment of ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis. A summary of liver and kidney assay data. ( Lamborn, KR; Lomen, PL; Turner, LF, 1986) |
| "Improvement of patients in all groups reached statistical significance after 1 month's treatment and remained significant at 12 months." | 2.66 | A long-term study of flurbiprofen in rheumatological disorders: III. Other articular conditions. ( Busson, M, 1986) |
| "Flurbiprofen appears to be an excellent alternative to phenylbutazone in the management of patients with ankylosing spondylitis." | 2.66 | Flurbiprofen in the treatment of ankylosing spondylitis. A comparison with phenylbutazone. ( Brinn, EL; Lamborn, KR; Lomen, PL; Sattler, LP; Turner, LF, 1986) |
| "Flurbiprofen is an excellent treatment for the control of pain and inflammation in patients with ankylosing spondylitis." | 2.66 | Flurbiprofen in the treatment of ankylosing spondylitis. A comparison with indomethacin. ( Brinn, EL; Lamborn, KR; Lomen, PL; Turner, LF, 1986) |
| "The pharmacokinetic profile of 200 mg sustained-release flurbiprofen capsules was compared in nine elderly (mean age 84." | 1.28 | A multiple dose pharmacokinetic and tolerance study of once daily 200 mg sustained-release flurbiprofen capsules in young and very elderly patients. ( Bird, A; Hamdy, RC; Hill, J; Hind, ID; Le Gallez, P, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (84.62) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burry, HC | 1 |
| Siebers, R | 1 |
| Rovenský, J | 1 |
| Miceková, D | 1 |
| Good, A | 1 |
| Mena, H | 1 |
| Doury, P | 1 |
| Pattin, S | 1 |
| Mena, HR | 2 |
| Willkens, RF | 1 |
| Good, AE | 1 |
| Brogden, RN | 1 |
| Heel, RC | 1 |
| Speight, TM | 1 |
| Avery, GS | 1 |
| Hamdy, RC | 1 |
| Bird, A | 1 |
| Le Gallez, P | 1 |
| Hill, J | 1 |
| Hind, ID | 1 |
| Busson, M | 1 |
| Sigidin, IaA | 1 |
| Murav'ev, IuV | 1 |
| Lomen, PL | 3 |
| Turner, LF | 3 |
| Lamborn, KR | 3 |
| Brinn, EL | 2 |
| Sattler, LP | 1 |
1 review available for flurbiprofen and Ankylosing Spondylarthritis
| Article | Year |
|---|---|
Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Drug Interactions; Flurbipr | 1979 |
9 trials available for flurbiprofen and Ankylosing Spondylarthritis
| Article | Year |
|---|---|
A comparison of flurbiprofen with naproxen in ankylosing spondylitis.
Topics: Clinical Trials as Topic; Double-Blind Method; Female; Flurbiprofen; Gastrointestinal Diseases; Huma | 1980 |
Treatment of ankylosing spondylitis with flurbiprofen and indomethacin.
Topics: Clinical Trials as Topic; Double-Blind Method; Female; Flurbiprofen; Humans; Indomethacin; Male; Pal | 1977 |
Comparative study of the effectiveness of flurbiprofen given twice or 3-times daily.
Topics: Adult; Aged; Drug Administration Schedule; Female; Flurbiprofen; Hip Joint; Humans; Male; Middle Age | 1977 |
Treatment of ankylosing spondylitis with flurbiprofen or phenylbutazone.
Topics: Clinical Trials as Topic; Drug Evaluation; Female; Flurbiprofen; Humans; Male; Phenylbutazone; Propi | 1977 |
Management of ankylosing spondylitis with flurbiprofen or indomethacin.
Topics: Adult; Clinical Trials as Topic; Drug Tolerance; Flurbiprofen; Humans; Indomethacin; Propionates; Sp | 1977 |
A long-term study of flurbiprofen in rheumatological disorders: III. Other articular conditions.
Topics: Adolescent; Adult; Aged; Arthritis; Child; Clinical Trials as Topic; Drug Therapy, Combination; Fema | 1986 |
[Experience with using a new antirheumatic drug flugalin].
Topics: Adult; Aged; Arthritis, Rheumatoid; Clinical Trials as Topic; Female; Flurbiprofen; Follow-Up Studie | 1985 |
Flurbiprofen in the treatment of ankylosing spondylitis. A comparison with phenylbutazone.
Topics: Adolescent; Adult; Drug Evaluation; Female; Flurbiprofen; Humans; Male; Middle Aged; Pain; Phenylbut | 1986 |
Flurbiprofen in the treatment of ankylosing spondylitis. A comparison with indomethacin.
Topics: Adolescent; Adult; Drug Evaluation; Female; Flurbiprofen; Humans; Indomethacin; Male; Middle Aged; P | 1986 |
3 other studies available for flurbiprofen and Ankylosing Spondylarthritis
| Article | Year |
|---|---|
Six-month prospective study to monitor the treatment of rheumatic diseases with sustained-release flurbiprofen.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Delayed-Act | 2000 |
A multiple dose pharmacokinetic and tolerance study of once daily 200 mg sustained-release flurbiprofen capsules in young and very elderly patients.
Topics: Adult; Aged; Aged, 80 and over; Aging; Arthritis, Rheumatoid; Capsules; Delayed-Action Preparations; | 1990 |
Safety of flurbiprofen in the treatment of ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis. A summary of liver and kidney assay data.
Topics: Alanine Transaminase; Alkaline Phosphatase; Arthritis, Rheumatoid; Aspartate Aminotransferases; Aspi | 1986 |